Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN109678853B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109678853B reveals a green one-pot dasatinib synthesis using ionic liquids, offering high purity and cost reduction for pharmaceutical manufacturing supply chains.